Ad is loading...
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
WAEMX
Price
$2.99
Change
-$0.03 (-0.99%)
Updated
Nov 15 closing price
Ad is loading...

RNWFX vs WAEMX

Header iconRNWFX vs WAEMX Comparison
Open Charts RNWFX vs WAEMXBanner chart's image
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Wasatch Emerging Markets Small Cap I
Price$2.99
Change-$0.03 (-0.99%)
VolumeN/A
CapitalizationN/A
RNWFX vs WAEMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. WAEMX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Buy and WAEMX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. WAEMX (320M). RNWFX pays higher dividends than WAEMX: RNWFX (1.51) vs WAEMX (0.00). RNWFX was incepted earlier than WAEMX: RNWFX (23 years) vs WAEMX (17 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. WAEMX (21.00). RNWFX has a lower initial minimum investment than WAEMX: RNWFX (250) vs WAEMX (2000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. WAEMX (10.74). RNWFX return over 5 years is better than : 17.17 vs. WAEMX (4.71).
RNWFXWAEMXRNWFX / WAEMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years17 years-
Gain YTD7.099-1.320-538%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B320M19,031%
Annual Yield % from dividends1.510.00-
Returns for 1 year11.5410.74107%
Returns for 3 years-14.55-35.6041%
Returns for 5 years17.174.71364%
Returns for 10 years41.0010.92376%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics